浙江中西医结合杂志
浙江中西醫結閤雜誌
절강중서의결합잡지
ZHEJIANG JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2015年
6期
531-533
,共3页
郑戴波%高聚伟%潘磊%陈培丰
鄭戴波%高聚偉%潘磊%陳培豐
정대파%고취위%반뢰%진배봉
小鼠%Lewis肺癌移植瘤%龙葵氯仿提取物%抑瘤%免疫反应
小鼠%Lewis肺癌移植瘤%龍葵氯倣提取物%抑瘤%免疫反應
소서%Lewis폐암이식류%룡규록방제취물%억류%면역반응
mice%Lewis lung carcinoma xenografts%chloroform extract from Solanum nlgrum L.%anti-tumor%immune response
目的:观察龙葵氯仿提取物对荷瘤鼠肿瘤生长及脾和胸腺指数的影响。方法建立Lewis肺癌移植瘤模型,将小鼠随机分为5组,荷瘤模型组予生理盐水(0.2mL/10g)灌胃,龙葵氯仿提取物高、中、低剂量组分别按50、25、12.5mL/kg剂量的龙葵氯仿提取物灌胃,环磷酰胺组予环磷酰胺(CTX)(20mg/kg)腹腔注射(每隔2天1次),共15天。停药后24h,处死小鼠,分别剥离瘤块、胸腺、脾脏组织称重,测定各组小鼠的肿瘤生长抑制率、脾指数和胸腺指数。结果氯仿高、中、低剂量组抑瘤率分别为25.36%、38.93%、13.57%;CTX组为51.43%。环磷酰胺组及氯仿高、中、低剂量组平均瘤重分别为(1.36±0.07)g、(2.09±0.16)g、(1.71±0.11)g和(2.42±0.07)g,与荷瘤模型组(2.80±0.04)g比较,差异有统计学意义(P<0.01、P<0.05)。与荷瘤模型组比较,氯仿中剂量组的胸腺指数和脾指数显著提高(分别为130.85%、131.04%),差异有统计学意义(P<0.01),CTX组则显著降低(分别为46.24%和74.69%),差异有统计学意义(P<0.01)。结论龙葵氯仿提取物具有抑制荷瘤小鼠移植瘤生长的作用,其机制可能为通过增加荷瘤小鼠的胸腺和脾脏的重量,抑制荷瘤小鼠胸腺和脾脏萎缩,增加小鼠抗肿瘤免疫反应。
目的:觀察龍葵氯倣提取物對荷瘤鼠腫瘤生長及脾和胸腺指數的影響。方法建立Lewis肺癌移植瘤模型,將小鼠隨機分為5組,荷瘤模型組予生理鹽水(0.2mL/10g)灌胃,龍葵氯倣提取物高、中、低劑量組分彆按50、25、12.5mL/kg劑量的龍葵氯倣提取物灌胃,環燐酰胺組予環燐酰胺(CTX)(20mg/kg)腹腔註射(每隔2天1次),共15天。停藥後24h,處死小鼠,分彆剝離瘤塊、胸腺、脾髒組織稱重,測定各組小鼠的腫瘤生長抑製率、脾指數和胸腺指數。結果氯倣高、中、低劑量組抑瘤率分彆為25.36%、38.93%、13.57%;CTX組為51.43%。環燐酰胺組及氯倣高、中、低劑量組平均瘤重分彆為(1.36±0.07)g、(2.09±0.16)g、(1.71±0.11)g和(2.42±0.07)g,與荷瘤模型組(2.80±0.04)g比較,差異有統計學意義(P<0.01、P<0.05)。與荷瘤模型組比較,氯倣中劑量組的胸腺指數和脾指數顯著提高(分彆為130.85%、131.04%),差異有統計學意義(P<0.01),CTX組則顯著降低(分彆為46.24%和74.69%),差異有統計學意義(P<0.01)。結論龍葵氯倣提取物具有抑製荷瘤小鼠移植瘤生長的作用,其機製可能為通過增加荷瘤小鼠的胸腺和脾髒的重量,抑製荷瘤小鼠胸腺和脾髒萎縮,增加小鼠抗腫瘤免疫反應。
목적:관찰룡규록방제취물대하류서종류생장급비화흉선지수적영향。방법건립Lewis폐암이식류모형,장소서수궤분위5조,하류모형조여생리염수(0.2mL/10g)관위,룡규록방제취물고、중、저제량조분별안50、25、12.5mL/kg제량적룡규록방제취물관위,배린선알조여배린선알(CTX)(20mg/kg)복강주사(매격2천1차),공15천。정약후24h,처사소서,분별박리류괴、흉선、비장조직칭중,측정각조소서적종류생장억제솔、비지수화흉선지수。결과록방고、중、저제량조억류솔분별위25.36%、38.93%、13.57%;CTX조위51.43%。배린선알조급록방고、중、저제량조평균류중분별위(1.36±0.07)g、(2.09±0.16)g、(1.71±0.11)g화(2.42±0.07)g,여하류모형조(2.80±0.04)g비교,차이유통계학의의(P<0.01、P<0.05)。여하류모형조비교,록방중제량조적흉선지수화비지수현저제고(분별위130.85%、131.04%),차이유통계학의의(P<0.01),CTX조칙현저강저(분별위46.24%화74.69%),차이유통계학의의(P<0.01)。결론룡규록방제취물구유억제하류소서이식류생장적작용,기궤제가능위통과증가하류소서적흉선화비장적중량,억제하류소서흉선화비장위축,증가소서항종류면역반응。
Objective To investigate the effects of chloroform extract from Solanum nlgrum L. on the growth of tumor, spleen index and thymus index of mice. Methods C57BL/6J mice were inoculated with Lewis lung carcino-ma cells and then were randomly divided into 5 groups: model group, high- , middle- and low-dosage chloroform extract groups, and cyclophosphamide group, with 8 mice in each group. Chloroform extract groups were given 50, 25, 12.5ml/kg chloroform extract of Solanum nlgrum L. by gavage, respectively. Cyclophosphamide group was given 20mg/kg of the drug by intraperitoneal injection every 3 days. Model group was given normal saline(0.2mL/10g) by gavage. The process lasted for 15d. After drug withdrawal for 24h, the mice were sacrificed and the tumor mass, thymus and spleen were taken out to be weighted for evaluation of inhibition rate, spleen index and thymus index. Results The inhibition rates were 25.36%, 38.93%, 13.57%, and 51.43% in high- , middle- , and low-dosage chloroform extract groups and cyclophosphamide group. The average tumor weights of cyclophosphamide group and high- , middle- , and low-dosage chloroform extract groups were 1.36 ±0.07g, 2.09 ±0.16g, 1.71 ±0.11g, 2.42 ±0.07g, respectively, which significantly differ from that of model group (2.80 ±0.04; P<0.01 or P<0.05). Compared with those of model group (13.58 ±1.95mg/10g and 147.40 ±13.90mg/10g), the thymus and spleen indexes of middle-dosage chloroform extract group increased 130.85% and 131.04%, respectively (P<0.01), and those of cyclophos-phamide group decreased 46.24% and 74.69%, respectively(P<0.01). Conclusion Chloroform extract from Solanumnlgrum L. may inhibit the growth of tumor in mice by enhancing the anti-tumor immune response of body through increasing thymus and spleen weights and suppressing their atrophy caused by tumor.